Cargando…

Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?

Detalles Bibliográficos
Autores principales:	Zheng, Zhenzhen, Chen, Riken, Zhang, Nuofu, Zhuang, Chunying, Lu, Jianmin, Zhong, Yue, Liu, Haimin, Hong, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663015/ https://www.ncbi.nlm.nih.gov/pubmed/34473936 http://dx.doi.org/10.1164/rccm.202105-1256LE

Ejemplares similares

Can N3 Period Duration Serve as a Predictor of Cognitive Dysfunction?
por: Zheng, Zhenzhen, et al.
Publicado: (2021)

Learning curve and analysis of curative effects after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Hong, Cheng, et al.
Publicado: (2023)

Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China
por: Hong, Cheng, et al.
Publicado: (2023)

Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
por: Hong, Cheng, et al.
Publicado: (2022)

circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
por: Sun, Xishi, et al.
Publicado: (2021)

Treatment of Pulmonary Hypertension: Is Triple Therapy Necessarily Better than Monotherapy?
por: Sun, Xishi, et al.
Publicado: (2021)

Carbonic Anhydrase Inhibitors: A New Dawn for the Treatment of Obstructive Sleep Apnea
por: Chen, Riken, et al.
Publicado: (2022)

CXCL10 levels in diagnosis and improved hemodynamics in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty
por: Hong, Cheng, et al.
Publicado: (2022)

Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
por: Wu, Yanjuan, et al.
Publicado: (2023)

Comparison of six assessment tools to screen for obstructive sleep apnea in patients with hypertension
por: Zheng, Zhenzhen, et al.
Publicado: (2021)

Mild Intermittent Hypoxia: A New Treatment Approach for Patients with Obstructive Sleep Apnea and Hypertension
por: Chen, Riken, et al.
Publicado: (2022)

Efficacy of computed tomography in diagnosing pulmonary hypertension: A systematic review and meta-analysis
por: Chen, Riken, et al.
Publicado: (2022)

Pulmonary Vasculature: A Target for COVID-19
por: Chen, Lingdan, et al.
Publicado: (2021)

Screening of Hub Genes Associated with Pulmonary Arterial Hypertension by Integrated Bioinformatic Analysis
por: Zeng, Yu, et al.
Publicado: (2021)

Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis
por: Zeng, Yu, et al.
Publicado: (2021)

Cognitive Dysfunction in Patients with Pulmonary Hypertension
por: Yuan, Ping, et al.
Publicado: (2022)

Pulmonary Hypertension in Glycogen Storage Disease Type II
por: Li, Hui-Ping, et al.
Publicado: (2018)

BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Chen, Lingdan, et al.
Publicado: (2020)

Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Effect of COVID-19 in Pulmonary Hypertension
por: Jha, Ajay Kumar
Publicado: (2022)

CBLN2 rs2217560 was Associated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus
por: Huang, Can, et al.
Publicado: (2018)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Exercise feature and predictor of prognosis in patients with pulmonary artery stenosis‐associated pulmonary hypertension
por: Li, Xin, et al.
Publicado: (2022)

Hematopoietic and Lung Platelet Biogenesis as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis
por: Saito, Shigeki, et al.
Publicado: (2022)

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension
por: Mohamed, Nura A., et al.
Publicado: (2016)

Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
por: Wang, Zi-Hao, et al.
Publicado: (2023)

Positron Emission Tomography: A Novel Approach to Detect Pulmonary Artery Hypertension at the Early Stage?
por: Tang, Ruidi, et al.
Publicado: (2020)

BET Bromodomain Inhibitors and Pulmonary Arterial Hypertension: Take Care of the Heart
por: Piquereau, Jérôme, et al.
Publicado: (2019)

More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Ning, Dong, et al.
Publicado: (2020)

Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Badagliacca, Roberto, et al.
Publicado: (2021)

Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure
por: Douschan, Philipp, et al.
Publicado: (2022)

Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
por: Honore, Patrick M., et al.
Publicado: (2022)

Impact of pulmonary hypertension in patients undergoing atrial fibrillation ablation: A nationwide study
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Toward a standardized multidisciplinary team approach in preterm infants at-risk for pulmonary hypertension
por: Kesting, Anne C., et al.
Publicado: (2021)

Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
por: Helgeson, Scott A., et al.
Publicado: (2022)

Pulmonary arterial stent for pulmonary trunk stenosis after size-mismatched lung transplantation
por: Xiao, Fei, et al.
Publicado: (2019)

Pulmonary Artery Pseudoaneurysm Secondary to Lung Inf lammation
por: Ishimoto, Shinichirou, et al.
Publicado: (2018)

Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer
por: Forbes, Lindsay M., et al.
Publicado: (2021)

Impact of psychiatric disorders on the hemodynamic and quality of life outcome of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a retrospective study
por: Hirose, Kazutoshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h2v1g7dovk4n6j8kpugf910mat